NCT00953381 - Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 2) | Biotech Hunter

Enrollment

235

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

March 31, 2005

Study Completion Date

May 31, 2005

Conditions

Duodenal Ulcer

Interventions

DRUG

5 mg ilaprazole

One 5-mg ilaprazole tablet (Livzon Pharm Group Inc., China) together with three placebo tablets and one placebo capsule in a package being taken orally each morning on an empty stomach for 4 weeks

DRUG

10 mg ilaprazole

Two 5-mg ilaprazole tablets (Livzon Pharm Group Inc., China) together with two placebo tablets and one placebo capsule in a package being taken orally each morning on an empty stomach for 4 weeks

DRUG

20 mg ilaprazole

Four 5-mg ilaprazole tablets together with one placebo capsule in a package being taken orally each morning on an empty stomach for 4 weeks

DRUG

20 mg omeprazole

One 20-mg omeprazole capsule (AstraZeneca, Losec) together with four placebo tablets in a package being taken orally each morning on an empty stomach for 4 weeks

Trial Locations (1)

Unknown

Peking University Third Hospital, Beijing